531 related articles for article (PubMed ID: 23540946)
1. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
2. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
3. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
4. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
5. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
7. Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
Koo HR; Cho N; Song IC; Kim H; Chang JM; Yi A; Yun BL; Moon WK
J Magn Reson Imaging; 2012 Jul; 36(1):145-51. PubMed ID: 22392859
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of breast cancer and correlation with prognostic factors.
Chang YW; Kwon KH; Choi DL; Lee DW; Lee MH; Lee HK; Yang SB; Kim Y; Seo DY
Acta Radiol; 2009 Nov; 50(9):990-8. PubMed ID: 19863408
[TBL] [Abstract][Full Text] [Related]
9. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
10. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
[TBL] [Abstract][Full Text] [Related]
11. MRI morphological classification of ductal carcinoma in situ (DCIS) correlating with different biological behavior.
Liu H; Peng W
Eur J Radiol; 2012 Feb; 81(2):214-7. PubMed ID: 21296513
[TBL] [Abstract][Full Text] [Related]
12. Two different types of ring-like enhancement on dynamic MR imaging in breast cancer: correlation with the histopathologic findings.
Kobayashi M; Kawashima H; Matsui O; Zen Y; Suzuki M; Inokuchi M; Noguchi M; Ohta T
J Magn Reson Imaging; 2008 Dec; 28(6):1435-43. PubMed ID: 19025952
[TBL] [Abstract][Full Text] [Related]
13. Breast MRI of pure ductal carcinoma in situ: sensitivity of diagnosis and influence of lesion characteristics.
Baur A; Bahrs SD; Speck S; Wietek BM; Krämer B; Vogel U; Claussen CD; Siegmann-Luz KC
Eur J Radiol; 2013 Oct; 82(10):1731-7. PubMed ID: 23743052
[TBL] [Abstract][Full Text] [Related]
14. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance mammography of invasive lobular versus ductal carcinoma: systematic comparison of 811 patients reveals high diagnostic accuracy irrespective of typing.
Dietzel M; Baltzer PA; Vag T; Gröschel T; Gajda M; Camara O; Kaiser WA
J Comput Assist Tomogr; 2010 Jul; 34(4):587-95. PubMed ID: 20657229
[TBL] [Abstract][Full Text] [Related]
18. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors.
Wan CF; Du J; Fang H; Li FH; Zhu JS; Liu Q
Radiology; 2012 Feb; 262(2):450-9. PubMed ID: 22282183
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma.
Jeh SK; Kim SH; Kim HS; Kang BJ; Jeong SH; Yim HW; Song BJ
J Magn Reson Imaging; 2011 Jan; 33(1):102-9. PubMed ID: 21182127
[TBL] [Abstract][Full Text] [Related]
20. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
